US37637Q1058 - Common Stock

Overall **GBCI** gets a fundamental rating of **2** out of 10. We evaluated **GBCI** against 405 industry peers in the **Banks** industry. **GBCI** may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, **GBCI** is valued expensive at the moment.

In the past year **GBCI** was profitable.

In the past 5 years **GBCI** has always been profitable.

With a **Return On Assets** value of **0.66%**, **GBCI** is not doing good in the industry: **61.44%** of the companies in the same industry are doing better.

The **Return On Equity** of **GBCI** (**5.87%**) is worse than **68.66%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.66% | ||

ROE | 5.87% | ||

ROIC | N/A |

ROA(3y)1.01%

ROA(5y)1.2%

ROE(3y)9%

ROE(5y)9.86%

ROIC(3y)N/A

ROIC(5y)N/A

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | N/A | ||

PM (TTM) | 23.3% | ||

GM | N/A |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-7.23%

PM growth 5Y-3.52%

GM growth 3YN/A

GM growth 5YN/A

Compared to 1 year ago, **GBCI** has about the same amount of shares outstanding.

The number of shares outstanding for **GBCI** has been increased compared to 5 years ago.

Compared to 1 year ago, **GBCI** has a worse debt to assets ratio.

With a **Debt to FCF ratio** value of **7.71**, **GBCI** is not doing good in the industry: **74.88%** of the companies in the same industry are doing better.

A Debt/Equity ratio of **0.59** indicates that **GBCI** is somewhat dependend on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.59 | ||

Debt/FCF | 7.71 | ||

Altman-Z | N/A |

ROIC/WACCN/A

WACC7.19%

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | N/A | ||

Quick Ratio | N/A |

Measured over the past years, **GBCI** shows a decrease in **Earnings Per Share**. The EPS has been decreasing by **-1.52%** on average per year.

The **Revenue** has been growing slightly by **7.95%** on average over the past years.

EPS 1Y (TTM)-34.14%

EPS 3Y-10.35%

EPS 5Y-1.52%

EPS Q2Q%-22%

Revenue 1Y (TTM)-10.61%

Revenue growth 3Y1.58%

Revenue growth 5Y7.95%

Sales Q2Q%6.12%

The **Revenue** is expected to grow by **9.43%** on average over the next years. This is quite good.

EPS Next Y-18.88%

EPS Next 2Y6.21%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year4.56%

Revenue Next 2Y9.43%

Revenue Next 3YN/A

Revenue Next 5YN/A

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

The **Price/Earnings** ratio is **28.80**, which means the current valuation is very expensive for **GBCI**.

Compared to the rest of the industry, the **Price/Earnings** ratio of **GBCI** indicates a rather expensive valuation: **GBCI** more expensive than 84.58% of the companies listed in the same industry.

When comparing the **Price/Earnings** ratio of **GBCI** to the average of the S&P500 Index (**31.73**), we can say **GBCI** is valued inline with the index average.

With a **Price/Forward Earnings** ratio of **20.83**, **GBCI** is valued on the expensive side.

76.87% of the companies in the same industry are cheaper than **GBCI**, based on the **Price/Forward Earnings** ratio.

When comparing the **Price/Forward Earnings** ratio of **GBCI** to the average of the S&P500 Index (**22.71**), we can say **GBCI** is valued inline with the index average.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 28.8 | ||

Fwd PE | 20.83 |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 22.32 | ||

EV/EBITDA | N/A |

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y6.21%

EPS Next 3YN/A

Compared to an average industry **Dividend Yield** of **3.38**, **GBCI** has a dividend in line with its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.91% |

The dividend of **GBCI** has a limited annual growth rate of **4.74%**.

Dividend Growth(5Y)4.74%

Div Incr Years0

Div Non Decr Years0

The dividend of **GBCI** is growing, but earnings are growing more, so the dividend growth is sustainable.

DP80.16%

EPS Next 2Y6.21%

EPS Next 3YN/A

**GLACIER BANCORP INC**

NYSE:GBCI (10/14/2024, 8:04:01 PM)

After market: 47.23 0 (0%)**47.23**

**+0.46 (+0.98%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupBanks

GICS IndustryBanks

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap5.36B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.91% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 28.8 | ||

Fwd PE | 20.83 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.66% | ||

ROE | 5.87% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | N/A | ||

PM (TTM) | 23.3% | ||

GM | N/A | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.03

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.59 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | N/A | ||

Quick Ratio | N/A | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-34.14%

EPS 3Y-10.35%

EPS 5Y

EPS Q2Q%

EPS Next Y-18.88%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-10.61%

Revenue growth 3Y1.58%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y